Hot Keywords
Abdominal wall reconstruction Dermal fillers Facial rejuvenation Abdominoplasty Blepharoplasty Body contouring Flap Breast surgery Fat grafting Cleft lip Hair transplantation Hand surgery Materials Microsurgery Neck rejuvenation Reconstructive surgery Wound healing Peripheral nerve repair Limb preservation

Plast Aesthet Res 2021;8:[Accepted].10.20517/2347-9264.2021.26@The Author(s) 2021
Accepted Manuscript
Open AccessReview

Periodontal bioengineering with mesenchymal stem cells

Correspondence Address: Dr. Nerea Sánchez, Etiology and Therapy of Periodontal and Peri-implant Diseases Research Group, Faculty of Odontology, University Complutense of Madrid. Plaza Ramón y Cajal s/n (Ciudad Universitaria), Madrid 28040, Spain.


© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (, which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.


Current periodontal regenerative therapies aim at restitution ad integrum of the periodontal attachment apparatus, which involves periodontal ligament, root cementum and alveolar bone. Guided tissue regeneration, bioactive agents and bone replacement grafts have been utilized in an attempt to fully restore the lost periodontal tissues. But their predictability has been limited and dependent on patient- and defect-related factors. Consequently, the treatment of most periodontal defects still lacks satisfactory and predictable outcomes. Cell therapies, based on the use of mesenchymal stem cells (MSCs), represent a promising therapeutic strategy, in light of recently available published preclinical investigations and clinical studies. The application of MSCs in humans is being performed by two different strategies 1) the ex vivo culture of undifferentiated MSCs from autologous or allogeneic sources, subjected to specific cell expansion and characterization/differentiation tests to obtain the required cell counts for transplantation; 2) the use of autologous tissue grafts and micrografts, which apart from MSCs, contain other biologically active cell populations and their extracellular matrix. This literature review has evaluated the current status of MSCs therapy applied for periodontal regeneration, describing not only their mechanism of action, but also their efficacy and safety according to the published evidence.

Cite This Article

Sanchez N, Sanz M. Periodontal bioengineering with mesenchymal stem cells. Plast Aesthet Res 2021;8:[Accept].

© 2016-2021 OAE Publishing Inc., except certain content provided by third parties